Effects of Developing a Mobile-based Interactive Simulation Scheme for Assisting the Personalized Hands-on Learning of Nasogastric Tube Insertion

• Sponsor: National Cheng-Kung University Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT05742659
• Collaborator: (none)
• Enrollment: 73
• Location: 1
• Arms: 2
• Actual Duration (Months): 9.1
• Patients Per Site Per Month: 8.1

Study Details

Study Description

Brief Summary

A mobile-based interactive simulation scheme (MISS) was proposed and developed to investigate its effects on facilitating hands-on learning of nasogastric tube insertion in undergraduate medical students.

Condition or Disease	Intervention/Treatment	Phase
Nasogastric Tube Insertion	Other: A mobile-based interactive simulation scheme (MISS)	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 73 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Effects of Developing a Mobile-based Interactive Simulation Scheme for Assisting the Personalized Hands-on Learning of Nasogastric Tube Insertion: a Randomized Controlled Trial
• Actual Study Start Date: Aug 17, 2020
• Actual Primary Completion Date: Oct 17, 2020
• Actual Study Completion Date: May 20, 2021

Arms and Interventions

Arm	Intervention/Treatment
Experimental: experimental group	Other: A mobile-based interactive simulation scheme (MISS); A mobile-based interactive simulation scheme (MISS) was proposed and developed to investigate its effects on facilitating hands-on learning of NG insertion in undergraduate medical students.
No Intervention: control group

Outcome Measures

Primary Outcome Measures

1. The 10-item evaluation questionnaire on Nasogastric tube insertion knowledge [one week]

   0-100. Zero is the worst, and 100 is the best.

2. The self-confidence scale (C-scale) [one week]

   1-5. One is high uncertainty, and five is complete certainty.

Secondary Outcome Measures

1. System Usability Scale (SUS) [one week]

   1-5. One is strongly disagree, and five is strongly agree.

2. The NASA-TLX (Task load index) [one week]

   1-5. One is strongly disagree, and five is strongly agree.

3. The overall learning satisfaction [one week]

   1-5 each. One is strongly disagree, and five is strongly agree. The questionnaire included 20 questions, divided into 11 categories: perceived enjoyment, comparison, diagnosis report, satisfaction, intension to use, perceived usefulness, perceived ease of use, image, output quality, result demonstrability, and cognitive load.

4. The OSCE (Objective Structured Clinical Examination) test [one week]

   0-100. Zero is the worst, and 100 is the best.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• fifth-year undergraduate medical students

• at least 20 years old

• without any practical clinical experience

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	National Cheng Kung University Hospital	Tainan		Taiwan	704

Sponsors and Collaborators

• National Cheng-Kung University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: National Cheng-Kung University Hospital
• ClinicalTrials.gov Identifier: NCT05742659
• Other Study ID Numbers: NCKUH-B-ER-109-194
• First Posted: Feb 24, 2023
• Last Update Posted: Feb 24, 2023
• Last Verified: Dec 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Feb 24, 2023